ANRO: Alto Neuroscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 114.62
Enterprise Value ($M) -56.92
Book Value ($M) 165.05
Book Value / Share 6.12
Price / Book 0.69
NCAV ($M) 156.97
NCAV / Share 5.82
Price / NCAV 0.73

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.81

Liquidity (mrq)
Quick Ratio 13.09
Current Ratio 13.09

Balance Sheet (mrq) ($M)
Current Assets 183.53
Assets 191.61
Liabilities 26.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Ra Capital Management, L.p. 7.70 49.78
11-14 13G Etkin Amit 5.40
11-12 13G Fmr Llc 8.77
11-08 13G BlackRock, Inc. 5.40 0.00
02-09 13G Falcon Edge Capital, LP 13.80
02-07 13G Point72 Asset Management, L.P. 6.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 15,258 331,088 4.61
2025-01-13 21,207 176,891 11.99
2025-01-10 39,716 261,786 15.17

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ADCT – ADC Therapeutics SA ANVS – Annovis Bio, Inc.
BHC – Bausch Health Companies Inc.


Financial data and stock pages provided by
Fintel.io